Asia Pacific Medical Cannabis Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2030 |
 Market Size (Base Year) |
|
 Market Size (Forecast Year) |
|
 CAGR |
% |
| Major Markets Players |
Asia-Pacific Medical Cannabis Market, By Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) - Industry Trends and Forecast to 2030.
Asia-Pacific Medical Cannabis Market Analysis and Insights
The rising number of patients related to chronic diseases Asia-Pacific and an increased inclination towards a healthy lifestyle are some of the factors that are expected to drive market growth. In addition, the rise in the number of product approvals and increasing R&D activities for medical cannabis devices are expected to drive market growth. However, the high cost of medical cannabis devices and procedures, medicinal drugs, safety concerns and adverse effects associated with laser procedures, and lack of awareness about the treatment from laser devices are expected to restrain the market growth. Additional technological advancements in medical cannabis and strategic initiatives by emerging players are expected to act as opportunities for market growth. However, stringent regulations and a lack of skilled professionals are expected to pose a challenge to market growth.
The use of cannabis as medicine is not rigorously tested due to government restrictions and resulting in limited clinical research to define the efficacy of cannabis in medical and clinical applications. However, preliminary studies suggest that cannabis reduces vomiting and nausea in chemotherapy patients and helps in increasing appetite.
Data Bridge Market Research analyzes that the Asia-Pacific medical cannabis market is expected to grow at a CAGR of 22.3% during the forecast period of 2023 to 2030.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Year |
2021 (Customizable to 2015 – 2020) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Product (Oil, Medical Cannabis Capsules, Patch, Whole Flower, Ground Flower, Vape Pen, Dried Medical Cannabis, Creams & Moisturizer, Masks & Serum, Cleanser, and Others), Source (Natural and Synthetic), Species (Cannabis Indica, Sativa, and Hybrid), Application (Alzheimer’s Disease, Appetite Loss, Cancer, Inflammatory Bowel Diseases, Eating Disorders, Epilepsy, Autism, Mental Health Conditions, Multiple Sclerosis, Pain Management, Nausea, Muscle Spasms, Wasting Syndrome (Cachexia), Elevate Mood, Depression and Sleep Disorders, Anxiety, and Others), Derivatives (Cannabidiol (CBD), Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and Others), Treatment Type (Expectorant, Antiviral, Analgesic, Aphrodisiac, Psychedelic, and Others), Route of Administration (Oral Solutions and Capsules, Smoking, Vaporizers, Topicals, and Others), End User (Pharmaceutical Industry, Research and Development Centers, Homecare Setting, Hospital, Rehab Centers, and Others), Distribution Channel (B2B and B2C) |
|
Countries Covered |
Australia, Thailand, South Korea, Japan, China, New Zealand, Singapore, India, Taiwan, Malaysia, Philippines, and Rest of Asia-Pacific |
|
Market Players Covered |
MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Asia-Pacific Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Asia-Pacific Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others |
Market Definition
Cannabis is a psychoactive drug that is derived from the cannabis plant of the Cannabaceae family. For several years, it has been used medicinally and has a wide range of applications in the treatment of various diseases including chronic pain, cancer, depression, diabetes, arthritis, glaucoma, epilepsy, migraines, AIDS, and Alzheimer’s among others.
The increased medicinal use of cannabis, the controlled legalization and use of cannabis in various industries, and the advanced methodologies present in the field are some of the factors expected to drive market growth.
Asia-Pacific Medical Cannabis Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increased use of cannabis in medicines
Medicinal cannabis is derived from cannabis plants and can be used to treat symptoms of certain medical conditions, and the side effects of some treatments. The most common form of medicinal use of cannabis is pain management. There has been gradual acceptance and use of medicinal cannabis with the growing number of countries that have legalized the use of cannabis for various indications. Medical cannabis has been approved for use by the FDA for three indications which are rare and severe forms of epilepsy, Dravet syndrome, and Lennox-Gastaut syndrome and also to treat the spasticity in Multiple Sclerosis (MS).
Medical marijuana uses the marijuana plant or chemicals in it to treat diseases or conditions apart from the approved drugs, there is an increased interest in two cannabinoids which are delta-9-tetrahydrocannabinol and cannabidiol. Tetrahydrocannabinol is shown to improve appetite, minimize fatigue, and manage muscle function issues while cannabidiol is effective for managing epileptic seizures, curing psychiatric illness, and reducing inflammation.
- Legalization of Cannabis
The use and acceptance of medicinal cannabis continue to evolve, as the growing number of states are permitting the use of specific medical indications. Many countries have legalized marijuana for either medicinal or recreational purposes while some other countries with restricted use. In recent years, a growing number of states in the U.S. have legalized the drug for medical or recreational purposes. With the widespread legalization of cannabis, many companies are also becoming proactive and are taking initiatives for the complete legalization of cannabis.
The legalization of marijuana in different parts of the world can be seen as an effort to increase the additional revenue, this way there will be a boost in the revenue without raising taxes. The legalization of cannabis will allow more consumption of it for medicinal or recreational purposes. Moreover, it will also boost the cannabis business, thus creating more demand for cannabis. Hence, the legalization of cannabis is expected to drive market growth.
Opportunities
- Novel product development with increasing R&D activities
Medicinal cannabis comes in many different forms including capsules, chewable gum, creams, crystals, flower, lozenges, oil, and oro-mucosal sprays. High growth in the demand for cannabis with legalization has increased the need to come up with better product strains and delivery systems. This has led many companies to conduct R&D activities to check the genetic improvement strategies for cannabis. The FDA's Cannabis Product Committee (CPC) develops and implements cross-Agency strategies and policies for the regulation of cannabis products. The novel products that are developed and on the rise are hemp protein powders, energy bars, hemp milk, hemp flour, and hemp tea, which are expected to create opportunities for market growth.
- Increased adoption of cannabis for recreational purpose
Legalizing recreational marijuana results in helpful regulation of a safe drug, without increasing potential negative consequences. The legalization of marijuana has various societal benefits as the rise in the economy without increasing taxes, creating thousands of job opportunities, stopping the racial differences in marijuana enforcement, and freeing up scarce police resources. Legal recreational marijuana can end the costly enforcement of marijuana laws and debilitate the illegal marijuana market.
Due to these benefits, marijuana has been legalized and is being increasingly adopted by people of different age groups. This creates a demand for good-quality marijuana for fun and relaxation. Hence, the increasing adoption of cannabis for recreational purposes is expected to create opportunities for manufacturers in the market.
Restraint/Challenge
- High-cost purchasing and rush for premium quality
Medical cannabis devices can be expensive to manufacture and purchase, and the procedure cost can also be high due to the specialized equipment and training required. This can limit the accessibility of medical cannabis treatments for patients and healthcare facilities, particularly in lower-income regions. Additionally, the high cost of medical cannabis devices and procedures may deter some patients from choosing these treatments, especially if they have to pay out of pocket. Insurance coverage for medical cannabis treatments can also be limited, limiting their adoption.
As a result, the high cost of medical cannabis devices and procedures can be a significant barrier to market growth, especially in regions where cost is a major factor. However, as technology advances, the cost of these devices and procedures may decrease, making them more accessible to patients and healthcare facilities.
The increased intricacy of medical cannabis devices and the high cost of medical cannabis treatment are expected to restrain the market growth.
Recent Development
- In May 2018, as per the Cannabis Act of the Government of Canada, the cannabis act will create a strict legal framework for controlling the production, distribution, sale, and possession of cannabis across Canada which is meant to keep cannabis out of the hands of youth and profits out of pockets of organized crime by fostering a robust legal and regulated industry.
Asia-Pacific Medical Cannabis Market Scope
The Asia-Pacific medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel. The growth amongst these segments will help you analyze market growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Oil
- Dried Medical Cannabis
- Medical Cannabis Capsules
- Vape Pen
- Whole Flower
- Creams & Moisturizer
- Ground Flower
- Patch
- Masks & Serum
- Cleanser
- Others
On the basis of product, the market is segmented into oil, medical cannabis capsules, patch, whole flower, ground flower, vape pen, dried medical cannabis, creams & moisturizer, masks & serum, cleanser, and others.
Source
- Synthetic
- Natural
On the basis of source, the market is segmented into synthetic and natural.
Species
- Cannabis Indica
- Sativa
- Hybrid
On the basis of species, the market is segmented into cannabis indica, sativa, and hybrid.
Derivatives
- Cannabidiol (CBD)
- Tetrahydrocannabinol (THC)/ Delta-8-Tetrahydrocannabinol
- Cannabigerol (CBG)
- Cannabichromene (CBC)
- Cannabinol (CBN)
- Cannabicyclol (CBL)
- Others
On the basis of derivatives, the market is segmented into Cannabidiol (CBD), tetrahydrocannabinol (THC)/delta-8-tetrahydrocannabinol, Cannabinol (CBN), Cannabicyclol (CBL), Cannabichromene (CBC), Cannabigerol (CBG), and others.
Application
- Pain Management
- Anxiety
- Muscle Spasm
- Nausea
- Appetite Loss
- Eating Disorders
- Inflammatory Bowel Diseases
- Cancer
- Arthritis
- Wasting Syndrome (Cachexia)
- Alzheimer’s Disease
- Epilepsy
- Depression and Sleep Disorder
- Multiple Sclerosis
- Autism
- Mental Health Conditions
- Elevate Mood
- Others
On the basis of application, the market is segmented into Alzheimer’s disease, appetite loss, cancer, inflammatory bowel diseases, eating disorders, epilepsy, autism, mental health conditions, multiple sclerosis, pain management, nausea, muscle spasms, wasting syndrome (cachexia), elevate mood, multiple sclerosis, depression and sleep disorders, anxiety, and others.
Route of Administration
- Oral Solutions and Capsules
- Smoking
- Vaporizers
- Topicals
- Others
On the basis of route of administration, the market is segmented into oral solutions and capsules, smoking, vaporizers, topicals, and others.
Treatment Type
- Analgesic
- Psychedelic
- Antiviral
- Aphrodisiac
- Expectorant
- Others
On the basis of treatment type, the market is segmented into expectorant, antiviral, analgesic, aphrodisiac, psychedelic, and others.
End User
- Homecare Setting
- Hospital
- Rehab Centers
- Pharmaceutical Industry
- Research and Development Centers
- Others
On the basis of end user, the market is segmented into pharmaceutical industry, research and development centers, homecare settings, hospital, rehab centers, and others.
Distribution Channel
- B2B
- B2C
On the basis of distribution channel, the market is segmented into B2B and B2C.
Asia-Pacific Medical Cannabis Market Regional Analysis/Insights
The Asia-Pacific medical cannabis market is segmented into nine notable segments based on product, source, species, derivatives, application, route of administration, treatment type, end user, and distribution channel.
The countries covered in this market report are Australia, Thailand, South Korea, Japan, China, New Zealand, Singapore, India, Taiwan, Malaysia, Philippines, and Rest of Asia-Pacific.
Australia is expected to dominate the Asia-Pacific medical cannabis market due to the presence of key manufacturers and advanced technological processes.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data
Competitive Landscape and Asia-Pacific Medical Cannabis Market Share Analysis
The Asia-Pacific medical cannabis market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, regional presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, brand analysis, product approvals, patents, product width and breadth, application dominance, and technology lifeline curve. The above data points provided are only related to the companies’ focus related to the market.
Some of the major market players operating in this market are MediPharm Labs Inc., Tilray, Aurora Cannabis, JAZZ Pharmaceuticals Inc. (GW Pharmaceuticals plc), HEXO Corp. (Zenabis Asia-Pacific Ltd), Cresco Labs, Peace Naturals Project Inc., CANOPY GROWTH CORPORATION, Medical Marijuana, Inc., Seed Cellar, EcoGen Biosciences, CANNABIS SEEDS USA, Seeds For Me, HUMBOLDT SEED COMPANY, Extractas, World Class Cannabis Seeds (Crop King Seeds), BARNEY'S FARM, FOLIUM BIOSCIENCES, PharmaHemp, Elixinol Asia-Pacific Limited, ENDOCA, Harmony, MARY’S nutritionals, LLC, Pure Ratios, Greenwich Biosciences, Inc., Upstate Elevator Supply Co., Apothecanna, BOL Pharma, and IDT Australia among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
5 INDUSTRY INSIGHTS
5.1 INDUSTRY INSIGHTS PATENT ANALYSIS
5.2 DRUG TREATMENT RATE BY MATURED MARKETS
5.3 DEMOGRAPHIC TRENDS: IMPACTS ON ALL INCIDENCE RATES
5.4 PATIENT FLOW DIAGRAM
5.5 KEY PRICING STRATEGIES
5.6 KEY PATIENT ENROLLMENT STRATEGIES
6 REGULATORY SCENARIO
6.1 AUSTRALIA
6.2 THAILAND
6.3 JAPAN
6.4 CHINA
6.5 NEW ZEALAND
6.6 SINGAPORE
6.7 INDIA
6.8 MALAYSIA
6.9 PHILIPPINES
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASED USE OF CANNABIS IN MEDICINES
7.1.2 LEGALIZATION OF CANNABIS
7.1.3 STRATEGIC INITIATIVES TAKEN BY KEY PLAYERS
7.1.4 RISE IN THE PREVALENCE OF DISEASES THAT REQUIRE THE USE OF CANNABIS
7.2 RESTRAINTS
7.2.1 COMPLEX REGULATORY STRUCTURE FOR THE USAGE OF CANNABIS
7.2.2 ADVERSE EFFECTS DUE TO LONG-TERM USE
7.2.3 HIGH-COST PURCHASING AND RUSH FOR PREMIUM QUALITY
7.3 OPPORTUNITIES
7.3.1 NOVEL PRODUCT DEVELOPMENT WITH INCREASING R&D ACTIVITIES
7.3.2 INCREASED ADOPTION OF CANNABIS FOR RECREATIONAL PURPOSES
7.3.3 GROWING GERIATRIC POPULATION
7.4 CHALLENGES
7.4.1 RISE OF THE CANNABIS BLACK MARKET
7.4.2 SIDE EFFECTS RELATED TO THE USE OF CANNABIS
7.4.3 SHORTAGE OF SKILLED PERSONNEL
8 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 OIL
8.2.1 OIL, BY TYPE
8.2.1.1 CBD OIL CONCENTRATES
8.2.1.2 CBD VAPE OIL
8.2.1.3 CBD TINCTURES
8.2.2 OIL, BY SOURCE
8.2.2.1 HEMP BASED
8.2.2.2 MARIJUANA BASED
8.2.3 OIL, BY SPECIES
8.2.3.1 SATIVA
8.2.3.2 HYBRID
8.2.3.3 CANNABIS INDICA
8.2.4 OIL, BY PRODUCT TYPE
8.2.4.1 BRANDED
8.2.4.1.1 PENGUIN CBD OIL
8.2.4.1.2 FAB CBD OIL
8.2.4.1.3 GREEN ROADS BROAD SPECTRUM CBD OIL
8.2.4.1.4 OTHERS
8.2.4.2 GENERIC
8.3 DRIED MEDICAL CANNABIS
8.3.1 CANNABIS INDICA
8.3.2 SATIVA
8.3.3 HYBRID
8.4 MEDICAL CANNABIS CAPSULES
8.4.1 MEDICAL CANNABIS CAPSULES, BY TYPE
8.4.1.1 OIL BASED CANNABIS CAPSULES
8.4.1.2 POWDER BASED CANNABIS CAPSULES
8.4.1.3 LIQUID BASED CANNABIS CAPSULES
8.4.1.4 OTHERS
8.4.2 MEDICAL CANNABIS CAPSULES, BY CONCENTRATES
8.4.2.1 HIGH CBD CAPSULES DIGITAL
8.4.2.2 HIGH THC CAPSULE
8.4.2.3 THC/CBD BALANCED CAPSULE
8.4.2.4 CBD ISOLATE CAPSULE
8.4.3 MEDICAL CANNABIS CAPSULES, BY SPECIES
8.4.3.1 SATIVA
8.4.3.2 CANNABIS INDICA
8.4.4 MEDICAL CANNABIS CAPSULES, BY PRODUCT TYPE
8.4.4.1 BRANDED
8.4.4.1.1 JOY NUTRITION
8.4.4.1.2 MEDTERRA ISOLATE CBD GEL CAPSULES
8.4.4.1.3 LAZARUS NATURALS
8.4.4.1.4 OTHERS
8.4.4.2 GENERIC
8.5 VAPE PEN
8.5.1 VAPE PEN, BY SPECIES
8.5.1.1 SATIVA
8.5.1.2 HYBRID
8.5.1.3 CANNABIS INDICA
8.5.2 VAPE PEN, BY PRODUCT TYPE
8.5.2.1 BRANDED
8.5.2.1.1 KANDYPENS RUBI
8.5.2.1.2 SOL E-NECTAR COLLECTOR
8.5.2.1.3 PAX ERA PRO-OIL VAPE PEN
8.5.2.2 GENERIC
8.6 WHOLE FLOWER
8.6.1 WHOLE FLOWER, SPECIES
8.6.1.1 SATIVA
8.6.1.2 HYBRID
8.6.1.3 CANNABIS INDICA
8.6.2 WHOLE FLOWER, PRODUCT TYPE
8.6.2.1 BRANDED
8.6.2.1.1 ASTER FARMS
8.6.2.1.2 RA FLOWER
8.6.2.1.3 BAD APPLE
8.6.2.2 GENERIC
8.7 CREAMS & MOISTURIZER
8.7.1 CREAMS & MOISTURIZER, BY SPECIES
8.7.1.1 SATIVA
8.7.1.2 HYBRID
8.7.1.3 CANNABIS INDICA
8.7.2 CREAMS & MOISTURIZER, BY PRODUCT TYPE
8.7.2.1 BRANDED
8.7.2.1.1 CBDFX MUSCLE & JOINT
8.7.2.1.2 ASPEN GREEN MUSCLE RELIEF COOLING CREAM
8.7.2.1.3 MEDTERRA PAIN CREAM
8.7.2.2 GENERIC
8.8 GROUND FLOWER
8.8.1 GROUND FLOWER, BY SPECIES
8.8.1.1 SATIVA
8.8.1.2 HYBRID
8.8.1.3 CANNABIS INDICA
8.8.2 GROUND FLOWER, BY PRODUCT TYPE
8.8.2.1 BRANDED
8.8.2.1.1 ASTER FARMS
8.8.2.1.2 RA FLOWER
8.8.2.1.3 BAD APPLE
8.8.2.2 GENERIC
8.9 PATCH
8.9.1 PATCH, BY TYPE
8.9.1.1 RESERVOIR
8.9.1.2 LAYER DRUG-IN-ADHESIVE
8.9.1.3 OTHERS
8.9.2 PATCH, BY SPECIES
8.9.2.1 SATIVA
8.9.2.2 CANNABIS INDICA
8.9.2.3 HYBRID
8.9.3 PATCH, BY PRODUCT TYPE
8.9.3.1 BRANDED
8.9.3.1.1 HEMP BOMBS
8.9.3.1.2 PUREKANA
8.9.3.1.3 PURE RATIOS
8.9.3.1.4 RESERVOIR
8.9.3.2 GENERIC
8.1 MASKS & SERUM
8.10.1 MASKS & SERUM, BY SPECIES
8.10.1.1 SATIVA
8.10.1.2 CANNABIS INDICA
8.10.1.3 HYBRID
8.10.2 MASKS & SERUM, BY PRODUCT TYPE
8.10.2.1 BRANDED
8.10.2.1.1 BUMP & SMOOTH CBD
8.10.2.1.2 FACIAL ESSENCE
8.10.2.1.3 OTHERS
8.10.2.2 GENERIC
8.11 CLEANSER
8.11.1 CLEANSER, BY SPECIES
8.11.1.1 SATIVA
8.11.1.2 HYBRID
8.11.1.3 CANNABIS INDICA
8.11.2 CLEANSER, BY PRODUCT TYPE
8.11.2.1 BRANDED
8.11.2.1.1 KIEHL’S
8.11.2.1.2 CBD 101
8.11.2.1.3 OTHERS
8.11.2.2 GENERIC
8.12 OTHERS
9 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES
9.1 OVERVIEW
9.2 SATIVA
9.3 HYBRID
9.4 CANNABIS INDICA
10 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES
10.1 OVERVIEW
10.2 CANNABIDIOL (CBD)
10.3 TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL
10.4 CANNABIGEROL (CBG)
10.5 CANNABICHROMENE (CBC)
10.6 CANNABINOL (CBN)
10.7 CANNABICYCLOL (CBL)
10.8 OTHERS
11 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION
11.1 OVERVIEW
11.2 PAIN MANAGEMENT
11.2.1 PAIN MANAGEMENT, BY TYPE
11.2.1.1 CHRONIC PAIN
11.2.1.2 NON-CANCER CHRONIC PAIN
11.2.1.3 NEUROLOGICAL PAIN
11.2.2 PAIN MANAGEMENT, BY PRODUCT
11.2.2.1 OIL
11.2.2.2 DRIED MEDICAL CANNABIS
11.2.2.3 MEDICAL CANNABIS CAPSULES
11.2.2.4 PATCH
11.2.2.5 GROUND FLOWER
11.2.2.6 CREAMS & MOISTURIZER
11.2.2.7 VAPE PEN
11.2.2.8 WHOLE FLOWER
11.2.2.9 MASKS & SERUM
11.2.2.10 CLEANSER
11.2.2.11 OTHERS
11.3 ANXIETY
11.3.1 OIL
11.3.2 DRIED MEDICAL CANNABIS
11.3.3 MEDICAL CANNABIS CAPSULES
11.3.4 PATCH
11.3.5 GROUND FLOWER
11.3.6 CREAMS & MOISTURIZER
11.3.7 VAPE PEN
11.3.8 WHOLE FLOWER
11.3.9 MASKS & SERUM
11.3.10 CLEANSER
11.3.11 OTHERS
11.4 MUSCLE SPASM
11.4.1 OIL
11.4.2 DRIED MEDICAL CANNABIS
11.4.3 MEDICAL CANNABIS CAPSULES
11.4.4 PATCH
11.4.5 GROUND FLOWER
11.4.6 CREAMS & MOISTURIZER
11.4.7 VAPE PEN
11.4.8 WHOLE FLOWER
11.4.9 MASKS & SERUM
11.4.10 CLEANSER
11.4.11 OTHERS
11.5 NAUSEA
11.5.1 OIL
11.5.2 DRIED MEDICAL CANNABIS
11.5.3 MEDICAL CANNABIS CAPSULES
11.5.4 PATCH
11.5.5 GROUND FLOWER
11.5.6 CREAMS & MOISTURIZER
11.5.7 VAPE PEN
11.5.8 WHOLE FLOWER
11.5.9 MASKS & SERUM
11.5.10 CLEANSER
11.5.11 OTHERS
11.6 APPETITE LOSS
11.6.1 OIL
11.6.2 DRIED MEDICAL CANNABIS
11.6.3 MEDICAL CANNABIS CAPSULES
11.6.4 PATCH
11.6.5 GROUND FLOWER
11.6.6 CREAMS & MOISTURIZER
11.6.7 VAPE PEN
11.6.8 WHOLE FLOWER
11.6.9 MASKS & SERUM
11.6.10 CLEANSER
11.6.11 OTHERS
11.7 EATING DISORDERS
11.7.1 OIL
11.7.2 DRIED MEDICAL CANNABIS
11.7.3 MEDICAL CANNABIS CAPSULES
11.7.4 PATCH
11.7.5 GROUND FLOWER
11.7.6 CREAMS & MOISTURIZER
11.7.7 VAPE PEN
11.7.8 WHOLE FLOWER
11.7.9 MASKS & SERUM
11.7.10 CLEANSER
11.7.11 OTHERS
11.8 INFLAMMATORY BOWEL DISEASES
11.8.1 OIL
11.8.2 DRIED MEDICAL CANNABIS
11.8.3 MEDICAL CANNABIS CAPSULES
11.8.4 PATCH
11.8.5 GROUND FLOWER
11.8.6 CREAMS & MOISTURIZER
11.8.7 VAPE PEN
11.8.8 WHOLE FLOWER
11.8.9 MASKS & SERUM
11.8.10 CLEANSER
11.8.11 OTHERS
11.9 CANCER
11.9.1 OIL
11.9.2 DRIED MEDICAL CANNABIS
11.9.3 MEDICAL CANNABIS CAPSULES
11.9.4 PATCH
11.9.5 GROUND FLOWER
11.9.6 CREAMS & MOISTURIZER
11.9.7 VAPE PEN
11.9.8 WHOLE FLOWER
11.9.9 MASKS & SERUM
11.9.10 CLEANSER
11.9.11 OTHERS
11.1 ARTHRITIS
11.10.1 OIL
11.10.2 DRIED MEDICAL CANNABIS
11.10.3 MEDICAL CANNABIS CAPSULES
11.10.4 PATCH
11.10.5 GROUND FLOWER
11.10.6 CREAMS & MOISTURIZER
11.10.7 VAPE PEN
11.10.8 WHOLE FLOWER
11.10.9 MASKS & SERUM
11.10.10 CLEANSER
11.10.11 OTHERS
11.11 WASHING SYNDROME (CACHEXIA)
11.11.1 OIL
11.11.2 DRIED MEDICAL CANNABIS
11.11.3 MEDICAL CANNABIS CAPSULES
11.11.4 PATCH
11.11.5 GROUND FLOWER
11.11.6 CREAMS & MOISTURIZER
11.11.7 VAPE PEN
11.11.8 WHOLE FLOWER
11.11.9 MASKS & SERUM
11.11.10 CLEANSER
11.11.11 OTHERS
11.12 ALZHEIMER’S DISEASE
11.12.1 OIL
11.12.2 DRIED MEDICAL CANNABIS
11.12.3 MEDICAL CANNABIS CAPSULES
11.12.4 PATCH
11.12.5 GROUND FLOWER
11.12.6 CREAMS & MOISTURIZER
11.12.7 VAPE PEN
11.12.8 WHOLE FLOWER
11.12.9 MASKS & SERUM
11.12.10 CLEANSER
11.12.11 OTHERS
11.13 EPILEPSY
11.13.1 OIL
11.13.2 DRIED MEDICAL CANNABIS
11.13.3 MEDICAL CANNABIS CAPSULES
11.13.4 PATCH
11.13.5 GROUND FLOWER
11.13.6 CREAMS & MOISTURIZER
11.13.7 VAPE PEN
11.13.8 WHOLE FLOWER
11.13.9 MASKS & SERUM
11.13.10 CLEANSER
11.13.11 OTHERS
11.14 DEPRESSION AND SLEEP DISORDER
11.14.1 OIL
11.14.2 DRIED MEDICAL CANNABIS
11.14.3 MEDICAL CANNABIS CAPSULES
11.14.4 PATCH
11.14.5 GROUND FLOWER
11.14.6 CREAMS & MOISTURIZER
11.14.7 VAPE PEN
11.14.8 WHOLE FLOWER
11.14.9 MASKS & SERUM
11.14.10 CLEANSER
11.14.11 OTHERS
11.15 MULTIPLE SCLEROSIS
11.15.1 OIL
11.15.2 DRIED MEDICAL CANNABIS
11.15.3 MEDICAL CANNABIS CAPSULES
11.15.4 PATCH
11.15.5 GROUND FLOWER
11.15.6 CREAMS & MOISTURIZER
11.15.7 VAPE PEN
11.15.8 WHOLE FLOWER
11.15.9 MASKS & SERUM
11.15.10 CLEANSER
11.15.11 OTHERS
11.16 AUTISM
11.16.1 OIL
11.16.2 DRIED MEDICAL CANNABIS
11.16.3 MEDICAL CANNABIS CAPSULES
11.16.4 PATCH
11.16.5 GROUND FLOWER
11.16.6 CREAMS & MOISTURIZER
11.16.7 VAPE PEN
11.16.8 WHOLE FLOWER
11.16.9 MASKS & SERUM
11.16.10 CLEANSER
11.16.11 OTHERS
11.17 MENTAL HEALTH CONDITIONS
11.17.1 MENTAL HEALTH CONDITIONS, BY TYPE
11.17.1.1 POSTTRAUMATIC STRESS DISORDER (PTSD)
11.17.1.2 SCHIZOPHRENIA
11.17.1.3 OTHERS
11.17.2 MENTAL HEALTH CONDITIONS, BY TYPE
11.17.2.1 OIL
11.17.2.2 DRIED MEDICAL CANNABIS
11.17.2.3 MEDICAL CANNABIS CAPSULES
11.17.2.4 PATCH
11.17.2.5 GROUND FLOWER
11.17.2.6 CREAMS & MOISTURIZER
11.17.2.7 VAPE PEN
11.17.2.8 WHOLE FLOWER
11.17.2.9 MASKS & SERUM
11.17.2.10 CLEANSER
11.17.2.11 OTHERS
11.18 ELEVATE MOOD
11.18.1 OIL
11.18.2 DRIED MEDICAL CANNABIS
11.18.3 MEDICAL CANNABIS CAPSULES
11.18.4 PATCH
11.18.5 GROUND FLOWER
11.18.6 CREAMS & MOISTURIZER
11.18.7 VAPE PEN
11.18.8 WHOLE FLOWER
11.18.9 MASKS & SERUM
11.18.10 CLEANSER
11.18.11 OTHERS
11.19 OTHERS
12 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 ORAL SOLUTIONS AND CAPSULES
12.3 SMOKING
12.4 TOPICALS
12.5 VAPORIZERS
12.6 OTHERS
13 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE
13.1 OVERVIEW
13.2 ANALGESIC
13.3 PSYCHEDELIC
13.4 ANTIVIRAL
13.5 APHRODISIAC
13.6 EXPECTORANT
13.7 OTHERS
14 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER
14.1 OVERVIEW
14.2 HOMECARE SETTING
14.3 HOSPITAL
14.4 REHAB CENTERS
14.5 PHARMACEUTICAL INDUSTRY
14.6 RESEARCH AND DEVELOPMENT CENTERS
14.7 OTHERS
15 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL
15.1 OVERVIEW
15.2 B2C
15.2.1 PHARMACIES
15.2.2 CONVENTIONAL STORES
15.2.3 ONLINE STORES
15.2.4 OTHERS
15.3 B2B
16 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY REGION
16.1 ASIA-PACIFIC
16.1.1 AUSTRALIA
16.1.2 THAILAND
16.1.3 SOUTH KOREA
16.1.4 JAPAN
16.1.5 CHINA
16.1.6 NEW ZEALAND
16.1.7 SINGAPORE
16.1.8 INDIA
16.1.9 TAIWAN
16.1.10 MALAYSIA
16.1.11 PHILIPPINES
16.1.12 REST OF ASIA-PACIFIC
17 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY LANDSCAPE
17.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
18 COMPANY PROFILE
18.1 MEDIPHARM LABS INC.
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 COMPANY SHARE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPMENTS
18.2 TILRAY
18.2.1 COMPANY SNAPSHOT
18.2.2 COMPANY SHARE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 AURORA CANNABIS
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 COMPANY SHARE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPMENTS
18.4 JAZZ PHARMACEUTICALS INC. (GW PHARMACEUTICALS PLC)
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 COMPANY SHARE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPMENTS
18.5 HEXO CORP. (ZENABIS ASIA PACIFIC LTD)
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 COMPANY SHARE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPMENTS
18.6 APOTHECANNA
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 BOL PHARMA
18.7.1 COMPANY SNAPSHOT
18.7.2 PRODUCT PORTFOLIO
18.7.3 RECENT DEVELOPMENTS
18.8 BARNEY’S FARM
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 CANOPY GROWTH CORPORATION
18.9.1 COMPANY SNAPSHOT
18.9.2 REVENUE ANALYSIS
18.9.3 PRODUCT PORTFOLIO
18.9.4 RECENT DEVELOPMENTS
18.1 CANNABIS SEEDS USA
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENT
18.11 CRESCO LABS
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENTS
18.12 ECOGEN BIOSCIENCES
18.12.1 COMPANY SNAPSHOT
18.12.2 PRODUCT PORTFOLIO
18.12.3 RECENT DEVELOPMENTS
18.13 ELIXINOL ASIA PACIFIC LIMITED
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENTS
18.14 ENDOCA
18.14.1 COMPANY SNAPSHOT
18.14.2 PRODUCT PORTFOLIO
18.14.3 RECENT DEVELOPMENT
18.15 EXTRACTAS
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENT
18.16 FOLIUM BIOSCIENCES
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENTS
18.17 GREENWICH BIOSCIENCES, INC.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 HARMONY
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 HUMBOLDT SEED COMPANY
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 IDT AUSTRALIA
18.20.1 COMPANY SNAPSHOT
18.20.2 REVENUE ANALYSIS
18.20.3 PRODUCT PORTFOLIO
18.20.4 RECENT DEVELOPMENTS
18.21 MARY’S NUTRITIONALS, LLC
18.21.1 COMPANY SNAPSHOT
18.21.2 PRODUCT PORTFOLIO
18.21.3 RECENT DEVELOPMENT
18.22 MEDICAL MARIJUANA, INC.
18.22.1 COMPANY SNAPSHOT
18.22.2 REVENUE ANALYSIS
18.22.3 PRODUCT PORTFOLIO
18.22.4 RECENT DEVELOPMENTS
18.23 PEACE NATURALS PROJECT INC.
18.23.1 COMPANY SNAPSHOT
18.23.2 PRODUCT PORTFOLIO
18.23.3 RECENT DEVELOPMENT
18.24 PHARMAHEMP
18.24.1 COMPANY SNAPSHOT
18.24.2 PRODUCT PORTFOLIO
18.24.3 RECENT DEVELOPMENT
18.25 PURE RATIOS
18.25.1 COMPANY SNAPSHOT
18.25.2 PRODUCT PORTFOLIO
18.25.3 RECENT DEVELOPMENT
18.26 SEEDS FOR ME
18.26.1 COMPANY SNAPSHOT
18.26.2 PRODUCT PORTFOLIO
18.26.3 RECENT DEVELOPMENT
18.27 SEED CELLAR
18.27.1 COMPANY SNAPSHOT
18.27.2 PRODUCT PORTFOLIO
18.27.3 RECENT DEVELOPMENT
18.28 UPSTATE ELEVATOR SUPPLY CO.
18.28.1 COMPANY SNAPSHOT
18.28.2 PRODUCT PORTFOLIO
18.28.3 RECENT DEVELOPMENT
18.29 WORLD CLASS CANNABIS SEEDS (CROP KING SEEDS)
18.29.1 COMPANY SNAPSHOT
18.29.2 PRODUCT PORTFOLIO
18.29.3 RECENT DEVELOPMENT
19 QUESTIONNAIRE
20 RELATED REPORTS
List of Table
TABLE 1 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 2 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 3 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 5 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 6 ASIA PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE 2021-2030 (USD MILLION)
TABLE 7 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 8 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 9 ASIA PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 10 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 11 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 12 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 13 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 14 ASIA PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 15 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 16 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 17 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 18 ASIA PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 19 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 20 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 21 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 22 ASIA PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 23 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 24 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 25 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 26 ASIA PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 27 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 28 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 29 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 30 ASIA PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 31 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 32 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 33 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 35 ASIA PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 36 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 37 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 38 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 39 ASIA PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 40 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 41 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 42 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 43 ASIA PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 44 ASIA PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 45 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 46 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 47 ASIA PACIFIC SATIVA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 48 ASIA PACIFIC HYBRID IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 49 ASIA PACIFIC CANNABIS INDICA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 50 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 51 ASIA PACIFIC CANNABIDIOL (CBD) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 52 ASIA PACIFIC TETRAHYDROCANNABINOL (THC)/DELTA-8-TETRAHYDROCANNABINOL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 53 ASIA PACIFIC CANNABIGEROL (CBG) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 54 ASIA PACIFIC CANNABICHROMENE (CBC) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 55 ASIA PACIFIC CANNABINOL (CBN) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 56 ASIA PACIFIC CANNABICYCLOL (CBL) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 57 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 58 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 59 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 60 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 61 ASIA PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 63 ASIA PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 64 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 65 ASIA PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 66 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 67 ASIA PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 68 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 69 ASIA PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 70 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 71 ASIA PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 72 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 73 ASIA PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 74 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 75 ASIA PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 77 ASIA PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 79 ASIA PACIFIC WASHING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 80 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 81 ASIA PACIFIC ALZHEIMER’S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 82 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 83 ASIA PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 84 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 85 ASIA PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 86 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 87 ASIA PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 88 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 89 ASIA PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 90 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 91 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 92 ASIA PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 93 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 94 ASIA PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 95 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 96 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 97 ASIA PACIFIC ORAL SOLUTIONS AND CAPSULES IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 98 ASIA PACIFIC SMOKING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 99 ASIA PACIFIC TOPICALS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 100 ASIA PACIFIC VAPORIZERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 101 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 102 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 103 ASIA PACIFIC ANALGESIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 104 ASIA PACIFIC PSYCHEDELIC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 105 ASIA PACIFIC ANTIVIRAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 106 ASIA PACIFIC APHRODISIAC IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 107 ASIA PACIFIC EXPECTORANT IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 108 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 109 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 110 ASIA PACIFIC HOMECARE SETTING IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 111 ASIA PACIFIC HOSPITAL IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 112 ASIA PACIFIC REHAB CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 113 ASIA PACIFIC PHARMACEUTICAL INDUSTRY IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 114 ASIA PACIFIC RESEARCH AND DEVELOPMENT CENTERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 115 ASIA PACIFIC OTHERS IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 116 ASIA PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 117 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 118 ASIA PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 ASIA PACIFIC B2B IN MEDICAL CANNABIS MARKET, BY REGION, 2021-2030 (USD MILLION)
TABLE 120 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 121 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 122 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 124 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 125 ASIA-PACIFIC OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 126 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 127 ASIA-PACIFIC DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 128 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 130 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 131 ASIA-PACIFIC MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 132 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 133 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 134 ASIA-PACIFIC VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 135 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 136 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 137 ASIA-PACIFIC WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 138 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 139 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 140 ASIA-PACIFIC CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 141 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 142 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 143 ASIA-PACIFIC GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 144 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 145 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 146 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 147 ASIA-PACIFIC PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 148 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 149 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 150 ASIA-PACIFIC MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 151 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 152 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 153 ASIA-PACIFIC CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 154 ASIA-PACIFIC BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 155 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 156 ASIA-PACIFIC SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 157 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 158 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 159 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 161 ASIA-PACIFIC PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 162 ASIA-PACIFIC ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 163 ASIA-PACIFIC MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 164 ASIA-PACIFIC NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 165 ASIA-PACIFIC APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 166 ASIA-PACIFIC EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 167 ASIA-PACIFIC INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 168 ASIA-PACIFIC CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 169 ASIA-PACIFIC ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 170 ASIA-PACIFIC WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 171 ASIA-PACIFIC ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 172 ASIA-PACIFIC EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 173 ASIA-PACIFIC DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 174 ASIA-PACIFIC MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 175 ASIA-PACIFIC AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 176 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 177 ASIA-PACIFIC MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 178 ASIA-PACIFIC ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 179 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 180 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 181 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 182 ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 183 ASIA-PACIFIC B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 184 AUSTRALIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 185 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 186 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 187 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 188 AUSTRALIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 189 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 190 AUSTRALIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 191 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 192 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 193 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 194 AUSTRALIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 195 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 196 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 197 AUSTRALIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 198 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 199 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 200 AUSTRALIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 201 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 202 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 203 AUSTRALIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 204 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 205 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 206 AUSTRALIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 207 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 208 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 209 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 210 AUSTRALIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 211 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 212 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 213 AUSTRALIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 214 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 215 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 216 AUSTRALIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 217 AUSTRALIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 218 AUSTRALIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 219 AUSTRALIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 220 AUSTRALIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 221 AUSTRALIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 222 AUSTRALIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 224 AUSTRALIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 225 AUSTRALIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 226 AUSTRALIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 227 AUSTRALIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 228 AUSTRALIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 229 AUSTRALIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 230 AUSTRALIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 231 AUSTRALIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 232 AUSTRALIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 233 AUSTRALIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 234 AUSTRALIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 235 AUSTRALIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 236 AUSTRALIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 237 AUSTRALIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 238 AUSTRALIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 239 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 240 AUSTRALIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 241 AUSTRALIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 242 AUSTRALIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 243 AUSTRALIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 244 AUSTRALIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 245 AUSTRALIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 246 AUSTRALIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 247 THAILAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 248 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 249 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 250 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 251 THAILAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 252 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 253 THAILAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 254 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 255 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 256 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 257 THAILAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 258 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 259 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 260 THAILAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 261 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 262 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 263 THAILAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 264 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 265 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 266 THAILAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 267 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 268 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 269 THAILAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 270 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 271 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 272 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 273 THAILAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 274 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 275 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 276 THAILAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 277 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 278 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 279 THAILAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 280 THAILAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 281 THAILAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 282 THAILAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 283 THAILAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 284 THAILAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 285 THAILAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 286 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 287 THAILAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 288 THAILAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 289 THAILAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 290 THAILAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 291 THAILAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 292 THAILAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 293 THAILAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 294 THAILAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 295 THAILAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 296 THAILAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 297 THAILAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 298 THAILAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 299 THAILAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 300 THAILAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 301 THAILAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 302 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 303 THAILAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 304 THAILAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 305 THAILAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 306 THAILAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 307 THAILAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 308 THAILAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 309 THAILAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 310 SOUTH KOREA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 311 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 312 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 313 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 314 SOUTH KOREA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 315 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 316 SOUTH KOREA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 317 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 318 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 319 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 320 SOUTH KOREA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 321 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 322 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 323 SOUTH KOREA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 324 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 325 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 326 SOUTH KOREA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 327 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 328 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 329 SOUTH KOREA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 330 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 331 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 332 SOUTH KOREA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 333 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 334 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 335 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 336 SOUTH KOREA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 337 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 338 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 339 SOUTH KOREA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 340 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 341 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 342 SOUTH KOREA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 343 SOUTH KOREA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 344 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 345 SOUTH KOREA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 346 SOUTH KOREA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 347 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 348 SOUTH KOREA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 349 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 350 SOUTH KOREA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 351 SOUTH KOREA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 352 SOUTH KOREA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 353 SOUTH KOREA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 354 SOUTH KOREA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 355 SOUTH KOREA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 356 SOUTH KOREA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 357 SOUTH KOREA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 358 SOUTH KOREA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 359 SOUTH KOREA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 360 SOUTH KOREA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 361 SOUTH KOREA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 362 SOUTH KOREA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 363 SOUTH KOREA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 364 SOUTH KOREA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 365 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 366 SOUTH KOREA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 367 SOUTH KOREA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 368 SOUTH KOREA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 369 SOUTH KOREA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 370 SOUTH KOREA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 371 SOUTH KOREA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 372 SOUTH KOREA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 373 JAPAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 374 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 375 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 376 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 377 JAPAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 378 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 379 JAPAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 380 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 381 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 382 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 383 JAPAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 384 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 385 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 386 JAPAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 387 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 388 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 389 JAPAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 390 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 391 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 392 JAPAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 393 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 394 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 395 JAPAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 396 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 397 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 398 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 399 JAPAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 400 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 401 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 402 JAPAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 403 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 404 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 405 JAPAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 406 JAPAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 407 JAPAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 408 JAPAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 409 JAPAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 410 JAPAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 411 JAPAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 412 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 413 JAPAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 414 JAPAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 415 JAPAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 416 JAPAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 417 JAPAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 418 JAPAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 419 JAPAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 420 JAPAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 421 JAPAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 422 JAPAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 423 JAPAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 424 JAPAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 425 JAPAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 426 JAPAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 427 JAPAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 428 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 429 JAPAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 430 JAPAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 431 JAPAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 432 JAPAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 433 JAPAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 434 JAPAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 435 JAPAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 436 CHINA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 437 CHINA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 438 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 439 CHINA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 440 CHINA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 441 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 442 CHINA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 443 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 444 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 445 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 446 CHINA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 447 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 448 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 449 CHINA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 450 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 451 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 452 CHINA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 453 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 454 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 455 CHINA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 456 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 457 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 458 CHINA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 459 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 460 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 461 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 462 CHINA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 463 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 464 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 465 CHINA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 466 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 467 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 468 CHINA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 469 CHINA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 470 CHINA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 471 CHINA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 472 CHINA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 473 CHINA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 474 CHINA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 475 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 476 CHINA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 477 CHINA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 478 CHINA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 479 CHINA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 480 CHINA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 481 CHINA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 482 CHINA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 483 CHINA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 484 CHINA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 485 CHINA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 486 CHINA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 487 CHINA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 488 CHINA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 489 CHINA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 490 CHINA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 491 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 492 CHINA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 493 CHINA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 494 CHINA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 495 CHINA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 496 CHINA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 497 CHINA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 498 CHINA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 499 NEW ZEALAND MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 500 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 501 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 502 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 503 NEW ZEALAND OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 504 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 505 NEW ZEALAND DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 506 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 507 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 508 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 509 NEW ZEALAND MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 510 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 511 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 512 NEW ZEALAND VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 513 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 514 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 515 NEW ZEALAND WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 516 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 517 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 518 NEW ZEALAND CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 519 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 520 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 521 NEW ZEALAND GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 522 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 523 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 524 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 525 NEW ZEALAND PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 526 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 527 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 528 NEW ZEALAND MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 529 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 530 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 531 NEW ZEALAND CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 532 NEW ZEALAND BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 533 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 534 NEW ZEALAND SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 535 NEW ZEALAND MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 536 NEW ZEALAND MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 537 NEW ZEALAND MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 538 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 539 NEW ZEALAND PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 540 NEW ZEALAND ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 541 NEW ZEALAND MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 542 NEW ZEALAND NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 543 NEW ZEALAND APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 544 NEW ZEALAND EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 545 NEW ZEALAND INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 546 NEW ZEALAND CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 547 NEW ZEALAND ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 548 NEW ZEALAND WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 549 NEW ZEALAND ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 550 NEW ZEALAND EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 551 NEW ZEALAND DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 552 NEW ZEALAND MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 553 NEW ZEALAND AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 554 NEW ZEALAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 555 NEW ZEALAND MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 556 NEW ZEALAND ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 557 NEW ZEALAND MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 558 NEW ZEALAND MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 559 NEW ZEALAND MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 560 NEW ZEALAND MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 561 NEW ZEALAND B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 562 SINGAPORE MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 563 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 564 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 565 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 566 SINGAPORE OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 567 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 568 SINGAPORE DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 569 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 570 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 571 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 572 SINGAPORE MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 573 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 574 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 575 SINGAPORE VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 576 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 577 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 578 SINGAPORE WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 579 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 580 SINGAPORE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 581 SINGAPORE CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 582 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 583 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 584 SINGAPORE GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 585 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 586 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 587 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 588 SINGAPORE PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 589 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 590 SINGAPORE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 591 SINGAPORE MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 592 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 593 SINGAPORE CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 594 SINGAPORE CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 595 SINGAPORE BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 596 SINGAPORE MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 597 SINGAPORE SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 598 SINGAPORE MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 599 SINGAPORE MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 600 SINGAPORE MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 601 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 602 SINGAPORE PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 603 SINGAPORE ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 604 SINGAPORE MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 605 SINGAPORE NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 606 SINGAPORE APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 607 SINGAPORE EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 608 SINGAPORE INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 609 SINGAPORE CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 610 SINGAPORE ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 611 SINGAPORE WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 612 SINGAPORE ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 613 SINGAPORE EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 614 SINGAPORE DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 615 SINGAPORE MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 616 SINGAPORE AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 617 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 618 SINGAPORE MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 619 SINGAPORE ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 620 SINGAPORE MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 621 SINGAPORE MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 622 SINGAPORE MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 623 SINGAPORE MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 624 SINGAPORE B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 625 INDIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 626 INDIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 627 INDIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 628 INDIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 629 INDIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 630 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 631 INDIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 632 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 633 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 634 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 635 INDIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 636 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 637 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 638 INDIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 639 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 640 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 641 INDIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 642 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 643 INDIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 644 INDIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 645 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 646 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 647 INDIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 648 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 649 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 650 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 651 INDIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 652 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 653 INDIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 654 INDIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 655 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 656 INDIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 657 INDIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 658 INDIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 659 INDIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 660 INDIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 661 INDIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 662 INDIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 663 INDIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 664 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 665 INDIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 666 INDIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 667 INDIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 668 INDIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 669 INDIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 670 INDIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 671 INDIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 672 INDIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 673 INDIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 674 INDIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 675 INDIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 676 INDIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 677 INDIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 678 INDIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 679 INDIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 680 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 681 INDIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 682 INDIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 683 INDIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 684 INDIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 685 INDIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 686 INDIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 687 INDIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 688 TAIWAN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 689 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 690 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 691 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 692 TAIWAN OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 693 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 694 TAIWAN DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 695 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 696 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 697 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 698 TAIWAN MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 699 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 700 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 701 TAIWAN VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 702 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 703 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 704 TAIWAN WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 705 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 706 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 707 TAIWAN CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 708 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 709 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 710 TAIWAN GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 711 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 712 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 713 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 714 TAIWAN PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 715 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 716 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 717 TAIWAN MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 718 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 719 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 720 TAIWAN CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 721 TAIWAN BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 722 TAIWAN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 723 TAIWAN SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 724 TAIWAN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 725 TAIWAN MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 726 TAIWAN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 727 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 728 TAIWAN PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 729 TAIWAN ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 730 TAIWAN MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 731 TAIWAN NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 732 TAIWAN APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 733 TAIWAN EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 734 TAIWAN INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 735 TAIWAN CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 736 TAIWAN ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 737 TAIWAN WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 738 TAIWAN ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 739 TAIWAN EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 740 TAIWAN DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 741 TAIWAN MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 742 TAIWAN AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 743 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 744 TAIWAN MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 745 TAIWAN ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 746 TAIWAN MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 747 TAIWAN MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 748 TAIWAN MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 749 TAIWAN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 750 TAIWAN B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 751 MALAYSIA MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 752 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 753 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 754 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 755 MALAYSIA OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 756 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 757 MALAYSIA DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 758 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 759 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 760 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 761 MALAYSIA MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 762 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 763 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 764 MALAYSIA VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 765 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 766 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 767 MALAYSIA WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 768 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 769 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 770 MALAYSIA CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 771 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 772 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 773 MALAYSIA GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 774 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 775 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 776 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 777 MALAYSIA PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 778 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 779 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 780 MALAYSIA MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 781 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 782 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 783 MALAYSIA CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 784 MALAYSIA BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 785 MALAYSIA MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 786 MALAYSIA SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 787 MALAYSIA MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 788 MALAYSIA MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 789 MALAYSIA MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 790 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 791 MALAYSIA PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 792 MALAYSIA ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 793 MALAYSIA MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 794 MALAYSIA NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 795 MALAYSIA APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 796 MALAYSIA EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 797 MALAYSIA INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 798 MALAYSIA CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 799 MALAYSIA ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 800 MALAYSIA WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 801 MALAYSIA ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 802 MALAYSIA EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 803 MALAYSIA DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 804 MALAYSIA MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 805 MALAYSIA AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 806 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 807 MALAYSIA MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 808 MALAYSIA ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 809 MALAYSIA MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 810 MALAYSIA MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 811 MALAYSIA MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 812 MALAYSIA MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 813 MALAYSIA B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 814 PHILIPPINES MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 815 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 816 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 817 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 818 PHILIPPINES OIL IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 819 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 820 PHILIPPINES DRIED MEDICAL CANNABIS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 821 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 822 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY CONCENTRATES, 2021-2030 (USD MILLION)
TABLE 823 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 824 PHILIPPINES MEDICAL CANNABIS CAPSULES IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 825 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 826 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 827 PHILIPPINES VAPE PEN IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 828 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 829 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 830 PHILIPPINES WHOLE FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 831 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 832 PHILIPPINES CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 833 PHILIPPINES CREAMS & MOISTURIZER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 834 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 835 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 836 PHILIPPINES GROUND FLOWER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 837 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 838 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 839 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 840 PHILIPPINES PATCH IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 841 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 842 PHILIPPINES MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 843 PHILIPPINES MASKS & SERUM IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 844 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 845 PHILIPPINES CLEANSER IN MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 846 PHILIPPINES CLEANSER IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 847 PHILIPPINES BRANDED IN MEDICAL CANNABIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 848 PHILIPPINES MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 849 PHILIPPINES SYNTHETIC IN MEDICAL CANNABIS MARKET, BY SOURCE, 2021-2030 (USD MILLION)
TABLE 850 PHILIPPINES MEDICAL CANNABIS MARKET, BY SPECIES, 2021-2030 (USD MILLION)
TABLE 851 PHILIPPINES MEDICAL CANNABIS MARKET, BY DERIVATIVES, 2021-2030 (USD MILLION)
TABLE 852 PHILIPPINES MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 853 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 854 PHILIPPINES PAIN MANAGEMENT IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 855 PHILIPPINES ANXIETY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 856 PHILIPPINES MUSCLE SPASM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 857 PHILIPPINES NAUSEA IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 858 PHILIPPINES APPETITE LOSS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 859 PHILIPPINES EATING DISORDERS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 860 PHILIPPINES INFLAMMATORY BOWEL DISEASES IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 861 PHILIPPINES CANCER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 862 PHILIPPINES ARTHRITIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 863 PHILIPPINES WASTING SYNDROME (CACHEXIA) IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 864 PHILIPPINES ALZHEIMER'S DISEASE IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 865 PHILIPPINES EPILEPSY IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 866 PHILIPPINES DEPRESSION AND SLEEP DISORDER IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 867 PHILIPPINES MULTIPLE SCLEROSIS IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 868 PHILIPPINES AUTISM IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 869 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 870 PHILIPPINES MENTAL HEALTH CONDITIONS IN MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 871 PHILIPPINES ELEVATE MOOD IN MEDICAL CANNABIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 872 PHILIPPINES MEDICAL CANNABIS MARKET, BY ROUTE OF ADMINISTRATION, 2021-2030 (USD MILLION)
TABLE 873 PHILIPPINES MEDICAL CANNABIS MARKET, BY TREATMENT TYPE, 2021-2030 (USD MILLION)
TABLE 874 PHILIPPINES MEDICAL CANNABIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 875 PHILIPPINES MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 876 PHILIPPINES B2C IN MEDICAL CANNABIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 877 REST OF ASIA-PACIFIC MEDICAL CANNABIS MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 ASIA PACIFIC MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 2 ASIA PACIFIC MEDICAL CANNABIS MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC MEDICAL CANNABIS MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC MEDICAL CANNABIS MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC MEDICAL CANNABIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC MEDICAL CANNABIS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 ASIA PACIFIC MEDICAL CANNABIS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 ASIA PACIFIC MEDICAL CANNABIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 ASIA PACIFIC MEDICAL CANNABIS MARKET: SEGMENTATION
FIGURE 11 INCREASING MEDICINAL USE AND LEGALIZATION OF MEDICAL CANNABIS ARE EXPECTED TO DRIVE THE ASIA PACIFIC MEDICAL CANNABIS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 PRODUCT SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC MEDICAL CANNABIS MARKET
FIGURE 14 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, 2022
FIGURE 19 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, 2023-2030 (USD MILLION)
FIGURE 20 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, CAGR (2023-2030)
FIGURE 21 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY SPECIES, LIFELINE CURVE
FIGURE 22 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2022
FIGURE 23 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, 2023-2030 (USD MILLION)
FIGURE 24 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, CAGR (2023-2030)
FIGURE 25 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DERIVATIVES, LIFELINE CURVE
FIGURE 26 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION, 2022
FIGURE 27 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION , 2023-2030 (USD MILLION)
FIGURE 28 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION , CAGR (2023-2030)
FIGURE 29 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2022
FIGURE 31 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, 2023-2030 (USD MILLION)
FIGURE 32 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, CAGR (2023-2030)
FIGURE 33 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 34 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2022
FIGURE 35 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, 2023-2030 (USD MILLION)
FIGURE 36 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, CAGR (2023-2030)
FIGURE 37 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY TREATMENT TYPE, LIFELINE CURVE
FIGURE 38 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, 2022
FIGURE 39 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 40 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 41 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 43 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 44 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 45 ASIA PACIFIC MEDICAL CANNABIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 ASIA-PACIFIC MEDICAL CANNABIS MARKET: SNAPSHOT (2022)
FIGURE 47 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2022)
FIGURE 48 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 49 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 50 ASIA-PACIFIC MEDICAL CANNABIS MARKET: BY PRODUCT (2023-2030)
FIGURE 51 ASIA PACIFIC MEDICAL CANNABIS MARKET: COMPANY SHARE 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
